ZP3022 is a dual agonist of glucagon-like peptide-1 (GLP-1) and gastrin that has the ability to sustainably improve glycemic control. Additionally, ZP3022 can effectively increase beta-cell mass, promote beta-cell proliferation, and enhance the function of pancreatic islets. ZP3022 can be used in anti-diabetic research[1].
Molekulargewicht:
4366.81
Reinheit:
98.00
CAS Nummer:
[1345835-12-2]
Formel:
C199H294N48O61S
Target-Kategorie:
GCGR
Anwendungsbeschreibung:
MCE Product type: Peptides
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten